Key Updates
EssilorLuxottica declined -2.26% to $208.00 since the March 10 report, extending YTD losses to -22.93% and reversing the brief +2.80% recovery observed two sessions ago. The ongoing weakness reflects persistent concerns about corporate governance tensions at parent holding company Delfin and broader market uncertainty surrounding Euronext's management of Italian exchanges. Despite strong operational performance with 7 million AI glasses sold in 2025 and 18% Q4 revenue growth, the stock continues to trade under pressure from margin compression and competitive threats from Apple and Google entering the smart glasses market in 2027.
Current Trend
EssilorLuxottica remains in a severe downtrend with -22.93% YTD losses and -21.42% decline over six months, trading at $208.00 after falling from November 2025 highs. The stock has experienced consecutive months of negative performance, with the 1-month decline of -16.97% accelerating the selloff. The brief +2.80% recovery on March 10 proved unsustainable, as the stock immediately resumed its downward trajectory with -2.26% decline. Technical momentum remains decisively negative across all timeframes, with the 5-day loss of -3.66% indicating continued selling pressure. The stock trades approximately 22% below its November record high, representing the largest gap to consensus price targets in absolute euro terms in company history.
Investment Thesis
The investment thesis centers on EssilorLuxottica's dominant position in the rapidly expanding smart glasses market through its partnership with Meta Platforms, which generated over 7 million unit sales in 2025—more than tripling from 2 million in 2023-2024 combined. The company delivered exceptional Q4 2025 revenue growth of 18% to €7.6 billion, significantly exceeding analyst expectations of 11%, driven by strong demand for Ray-Ban Meta and Oakley AI-powered glasses. The 10-year partnership extension with Meta and plans to expand production capacity to 20-30 million units annually position EssilorLuxottica as the market leader in wearable tech. However, the thesis faces headwinds from margin compression (adjusted operating margin declined 70 basis points to 16% in 2025), emerging competition from Apple's 2027 smart glasses launch and Google's partnership with Kering, and pricing tensions with Meta over maintaining luxury segment margins versus rapid market share expansion.
Thesis Status
The investment thesis remains fundamentally intact but faces mounting execution risks. Operational performance validates the growth narrative, with 7 million AI glasses sold representing a threefold increase and Q4 revenue surging 18% versus 11% consensus expectations. The company maintains its leadership position with Meta's partnership extended through the next decade and production capacity expansion underway. However, the 22% stock decline since November highs reflects legitimate investor concerns about margin sustainability, as adjusted gross margin fell 2.6 percentage points to 60.9% in 2025, with AI glasses accounting for two-thirds of the impact. The emergence of Apple and Google as competitors in 2027, combined with ongoing pricing disputes with Meta over balancing volume growth against luxury margins, introduces uncertainty around long-term profitability. Corporate governance issues at Delfin, where Leonardo Maria Del Vecchio's proposed €14 billion acquisition of siblings' stakes aims to resolve a three-year stalemate, add another layer of risk. The thesis requires successful navigation of margin pressures while defending market share against well-capitalized tech giants.
Key Drivers
Corporate governance developments at parent holding company Delfin continue to weigh on investor sentiment, with Leonardo Maria Del Vecchio's proposed €14 billion acquisition of 25% additional stake from siblings Luca and Paola aimed at resolving the three-year governance stalemate that has prevented dividend distributions above 10% of net profit. Separately, Italian state lender CDP's lawsuit against Euronext over CEO selection at Borsa Italiana reflects broader tensions in Italian financial markets, creating uncertainty for major Italian-listed companies including EssilorLuxottica. The pricing tensions with Meta remain unresolved, with Meta CEO Mark Zuckerberg advocating for lower pricing to rapidly scale adoption while EssilorLuxottica prioritizes maintaining luxury segment margins, creating ongoing margin pressure as the partnership scales toward 20-30 million unit production capacity. Competitive threats intensified with Apple's planned 2027 AI-powered eyewear launch following Google's December announcement, though analysts view this as potentially expanding the total addressable market rather than directly threatening EssilorLuxottica's established distribution advantages.
Technical Analysis
EssilorLuxottica exhibits severe technical weakness across all timeframes, with the stock at $208.00 representing a -22.93% YTD decline and -21.42% loss over six months. The brief +2.80% recovery to $212.80 on March 10 failed to establish any sustainable support, immediately reversing with -2.26% decline to current levels. The 1-month loss of -16.97% indicates accelerating downside momentum, while the 5-day decline of -3.66% confirms continued selling pressure. The stock trades approximately 22% below November 2025 record highs, creating the largest gap to consensus analyst price targets in absolute euro terms in company history. At 32 times expected earnings, the valuation remains 15% more expensive than European luxury stocks and at an 83% premium to the Stoxx 600 Health Care Index, suggesting limited valuation support despite the significant decline. The failure to hold the March 10 recovery level at $212.80 establishes resistance, while the November highs near $266 represent a distant technical ceiling. No clear support levels have emerged in the current downtrend, with momentum indicators pointing to continued weakness absent a fundamental catalyst.
Bull Case
- Exceptional smart glasses revenue growth with 7 million units sold in 2025, tripling from 2 million in 2023-2024 combined, establishing market leadership in wearable tech: CNBC reports the company more than tripled Meta AI glasses sales, while Bloomberg confirms this drove 18% Q4 sales surge to €7.6 billion, significantly exceeding 11% analyst expectations.
- 10-year partnership extension with Meta and planned production capacity expansion to 20-30 million units annually secures long-term growth runway: CNBC reports the partnership extended through the next decade with Meta acquiring at least a 3% stake, while Bloomberg confirms discussions to double production capacity to meet growing consumer demand.
- Strong credit ratings and insurance subsidiary performance provide financial stability and vertical integration advantages: Business Wire reports AM Best affirmed EyeMed Insurance Company's A (Excellent) Financial Strength Rating with stable outlook, citing very strong risk-adjusted capitalization and solid profitability measures supporting EssilorLuxottica's vertically integrated business model.
- Overwhelming analyst support with 25 buy ratings versus one sell recommendation and average price target suggesting 30% upside potential: Bloomberg reports analysts remain largely optimistic despite competitive pressures, with 23 of 27 analysts maintaining buy ratings and consensus targets implying significant recovery potential.
- Apple and Google market entry may expand total addressable market rather than cannibalizing existing business, leveraging EssilorLuxottica's distribution advantages: WSJ reports analysts view Apple's entry as potentially expanding the market, while Bloomberg confirms some analysts see new entrants as catalysts for market expansion given EssilorLuxottica's strong branding and distribution network.
Bear Case
- Severe margin compression with adjusted gross margin declining 2.6 percentage points to 60.9% in 2025, with AI glasses accounting for two-thirds of the impact: Bloomberg reports margin pressure from factory expansion costs and expensive electronic components, while adjusted operating margin declined 70 basis points to 16% due to production scaling costs and tariffs.
- Unresolved pricing tensions with Meta threaten profitability as Zuckerberg advocates for lower pricing versus EssilorLuxottica's luxury margin priorities: Bloomberg details fundamental strategic conflict with Meta CEO pushing for rapid volume expansion at lower prices while EssilorLuxottica prioritizes maintaining luxury segment profit margins as production scales to 20-30 million units.
- Apple's 2027 AI-powered eyewear launch and Google's partnership with Kering introduce well-capitalized competitors with superior technology capabilities: Bloomberg reports the stock suffered its worst week in nearly four years on Apple's announcement, with emerging competition from Google's Kering partnership and Alibaba's Chinese market entry intensifying competitive pressures.
- Corporate governance stalemate at Delfin holding company has prevented dividend distributions above 10% of net profit for three years: Reuters reports disagreements among eight heirs holding equal 12.5% stakes have blocked major governance changes and dividend policies since founder's 2022 death, while Bloomberg confirms Leonardo Maria Del Vecchio's €14 billion acquisition proposal represents ongoing uncertainty.
- Excessive valuation at 32x expected earnings trades 15% above European luxury stocks and 83% premium to Stoxx 600 Health Care Index despite operational challenges: Bloomberg reports the stock remains significantly more expensive than sector peers despite 22% decline from November highs, limiting downside protection as margin pressures persist and competitive threats intensify through 2027.